Yıl: 2023 Cilt: 39 Sayı: 3 Sayfa Aralığı: 197 - 203 Metin Dili: İngilizce DOI: 10.47717/turkjsurg.2023.5946 İndeks Tarihi: 02-11-2023

Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer

Öz:
Objective: In our study, it was aimed to evaluate the factors affecting oncological outcomes in resections for rectal cancer. Material and Methods: Between January 2010 and December 2014, patients with rectal tumors were analyzed retrospectively. Demographic and pathological data and oncological outcomes were analyzed as disease-free survival, overall survival, and local recurrence. Results: A total of 158 patients’ data were obtained. Median age was 60 (22-83). Fifty-three patients were older than 65 years of age (138). Ninety-five (60%) patients were males, and 63 (40%) were females. Eighty patients (50.4%) had middle rectal, and 78 (49.6) patients had lower rectal cancer. There was no effect of tumor localization on oncological outcomes. Univariate analyses revealed the effects of age (p= 0.003), operation type (p< 0.001), nodal status (p< 0.001), malignant lymph node ratio (p< 0.001), stage of the disease (p< 0.001), distal resection margin (p= 0.047), perineural invasion (p< 0.001), lymphatic invasion (p< 0.001), venous-vascular invasion (p= 0.025), local recurrence (p< 0.001) and distant metastasis (p< 0.001) on overall survival rates. Univariate analyses revealed the effects of nodal status (p= 0.007), malignant lymph node ratio (p= 0.005), stage of the disease (p= 0.008), perineural invasion (p= 0.004) and venous-vascular invasion (p< 0.001) on disease-free survival rates. Univariate analyses revealed the effects of anastomotic leak (p= 0.015) and venous-vascular invasion (p= 0.001) on local recurrence rates. Conclusion: Older age, advanced nodal status, and distant metastasis were detected as independent risk factors for overall survival. Perineural and venous-vascular invasion were detected as independent risk factors for disease-free survival. Lastly, anastomotic leak and venous-vascular invasion were detected as independent risk factors for local recurrence.
Anahtar Kelime: Rectal cancer rectal surgery survival local recurrence

Orta ve distal yerleşimli rektum kanserinin cerrahi rezeksiyonlarında onkolojik sonuçlara etkili faktörler

Öz:
Giriş ve Amaç: Çalışmamızda rektum kanseri rezeksiyonlarında onkolojik sonuçları etkileyen faktörleri değerlendirmeyi amaçladık. Gereç ve Yöntem: Ocak 2010 ile Aralık 2014 tarihleri arasında rektum tümörü olan ve ameliyat edilen hastalar retrospektif olarak incelendi. Demografik ve patolojik verilerin yanında onkolojik sonuçlar, hastalıksız sağkalım, genel sağkalım ve lokal nüks olarak incelendi. Bulgular: Toplam 158 hasta çalışmaya dahil edildi. Ortanca yaş 60 (22-83) idi. Elli üç hasta 65 yaşından büyüktü (138). Hastaların 95’i (%60) erkek, 63’ü (%40) kadın idi. Seksen (%50,4) hastada orta, 78 (49,6) hastada alt rektum kanseri vardı. Tümör lokalizasyonunun onkolojik sonuçlar üzerinde etkisi yoktu. Tek değişkenli analizlerde sağkalıma etkili faktörler yaş (p= 0,003), operasyon tipi (p< 0,001), nodal durum (p< 0,001), malign lenf nodu oranı (p< 0,001), hastalığın evresi (p< 0,001), distal rezeksiyon sınırı (p= 0,047), perinöral invazyon (p< 0,001), lenfatik invazyon (p< 0,001), venöz-vasküler invazyon (p= 0,025), lokal nüks (p< 0,001) ve uzak metastaz (p< 0,001) olması saptandı. Tek değişkenli analizlerde hastalıksız sağkalım için etkili faktörler; ileri nodal durum (p= 0,007), malign lenf nodu oranı (p= 0,005), hastalığın evresi (p= 0,008), perinöral invazyon (p= 0,004) ve venöz-vasküler invazyon (p< 0,001) olması saptandı. Tek değişkenli analizlerde lokal nükse etkili faktörler olarak anastomoz kaçağı- nın olması (p= 0,015) ve venöz-vasküler invazyonun (p= 0,001) olması saptandı. Sonuç: İleri yaş, ileri nodal durum ve uzak metastaz gelişmesi genel sağkalım için bağımsız risk faktörleri olarak saptandı. Perinöral ve venöz- vasküler invazyon hastalıksız sağkalım için bağımsız risk faktörleri olarak tespit edildi. Son olarak anastomoz kaçağı gelişmesi ve venöz-vasküler invazyon olması lokal nüks için bağımsız risk faktörleri olarak tespit edildi.
Anahtar Kelime: Rektum kanseri rektum cerrahisi sağkalım lokal nüks

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 1982; 69(10): 613-6. https://doi.org/10.1002/bjs.1800691019
  • 2. Heald RJ, Moran BJ, Rydall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133(8): 894-9. https://doi.org/10.1001/ archsurg.133.8.894
  • 3. Heald RJ. The “Holy Plane” of rectal surgery. J R Soc Med 1988; 81(9): 503-8. https://doi.org/10.1177/014107688808100904
  • 4. Hojo K, Sawada, Moriya Y. An analysis of survival and voiding, sexual function after wide iliopelvic lymphadenectomy in patient with adenocarcinoma of the rectum, compared with conventional lymphadenectomy. Dis Colon Rectum 1989; 32(2): 128-33. https://doi. org/10.1007/BF02553825
  • 5. Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients. Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003; 55(5): 1311-20. https://doi.org/10.1016/S0360-3016(02)04291-8
  • 6. Swedish Rectal Cancer Trial. Local recurrence rate in a randomized multicentre trial of preoperative radiotherapy compared to surgery alone in resectable rectal carcinoma. Eur J Surg 1996(5): 397-402.
  • 7. Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336(14): 980-7. https://doi.org/10.1056/ NEJM199704033361402
  • 8. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345(9): 638-46. https://doi.org/10.1056/NEJMoa010580
  • 9. Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. Rectal Cancer, Version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2018; 16(7): 874-901. https://doi.org/10.6004/jnccn.2018.0061
  • 10. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010 Jun; 17(6): 1471-4. https://doi.org/10.1245/ s10434-010-0985-4
  • 11. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64(2): 104-17. https://doi.org/10.3322/caac.21220
  • 12. Allaix ME, Giraudo G, Ferrarese A, Arezzo A, Rebecchi F, Morino M. 10- year oncologic outcomes after laparoscopic or open total mesorectal excision for rectal cancer. World J Surg 2016; 40(12): 3052-62. https:// doi.org/10.1007/s00268-016-3631-x
  • 13. Tilly C, Lefèvre JH, Svrcek M, Shields C, Fléjou JF, Tiret E, et al. R1 rectal resection: Look up and don’t look down. Ann Surg 2014; 260(5): 794-9;discussion 799-800. https://doi.org/10.1097/SLA.0000000000000988
  • 14. Shin DW, Shin JY, Oh SJ, Park JK, Yu H, Ahn MS, et al. The prognostic value of circumferential resection margin involvement in patients with extraperitoneal rectal cancer. Am Surg 2016; 82(4): 348-55. https://doi. org/10.1177/000313481608200421
  • 15. Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, GlynneJones R, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 2016; 103(5): 572-80. doi: 10.1002/bjs.10075. PMID: 26994716. https://doi.org/10.1002/ bjs.10075
  • 16. AJCC Cancer staging manual. 7th Edition; 40-6.
  • 17. Zuo ZG, Zhang XF, Wang H, Liu QZ, Ye XZ, Xu C, et al. Prognostic value of lymph node ratio in locally advanced rectal cancer patients after preoperative chemoradiotherapy followed by total mesorectal excision. Medicine (Baltimore) 2016; 95(9): e2988. https://doi.org/10.1097/ MD.0000000000002988
  • 18. Kim YW, Kim NK, Min BS, Lee KY, Sohn SK, Cho CH. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 2009; 249(6): 965-72. https://doi.org/10.1097/ SLA.0b013e3181a6cc25
  • 19. Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimizes patients staging in colorectal cancer. Br J Cancer 2009; 100(10): 1530-3. https://doi.org/10.1038/ sj.bjc.6605049
  • 20. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: A single-center analysis of 3.026 patients over a 25-year time period. Ann Surg 2008; 248(6): 968-78. https://doi.org/10.1097/ SLA.0b013e318190eddc
  • 21. Kanso F, Lefevre JH, Svrcek M, Chafai N, Parc Y, Tiret E. Partial mesorectal excision for rectal adenocarcinoma: Morbidity and oncological outcome. Clin Colorectal Cancer 2016; 15(1): 82-90.e1. https://doi. org/10.1016/j.clcc.2015.07.008
  • 22. Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A 5- to 21- year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 1988; 208(3): 379-89. https://doi.org/10.1097/00000658- 198809000-00016
  • 23. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95(2): 229-36. https://doi.org/10.1002/bjs.5917
  • 24. Chand M, Swift RI, Chau I, Heald RJ, Tekkis PP, Brown G. Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. Ann R Coll Surg Engl 2014; 96(7): 543-6. https://doi.org/10.1308/003 588414X13814021678835
  • 25. Koedam TWA, Bootsma BT, Deijen CL, van de Brug T, Kazemier G, Cuesta MA, et al. Oncological outcomes after anastomotic leakage after surgery for colonor rectal cancer: Increased risk of local recurrence. Ann Surg. 2022; 275(2): e420-e427. https://doi.org/10.1097/ SLA.0000000000003889
  • 26. Bao QR, Pellino G, Spolverato G, Restivo A, Deidda S, Capelli G, et al. The impact of the anastomotic leak on long-term oncological outcomes after low anterior resection for mid-low rectal cancer: Extended follow-up of a randomized controlled trial. Int J Colorectal Dis 2022; 37(7): 1689-98. https://doi.org/10.1007/s00384-022-04204-9
  • 27. Crippa J, Duchalais E, Machairas N, Merchea A, Kelley SR, Larson DW. Long-term oncological outcomes following anastomotic leak in rectal cancer surgery. Dis Colon Rectum 2020; 63(6): 769-77. https://doi. org/10.1097/DCR.0000000000001634
  • 28. Hasegawa H, Matsuda T, Arimoto A, Yamashita K, Nishi M, Takase N, et al. Does anastomotic leakage after rectal cancer resection worsen long-term oncologic outcome? Int J Colorectal Dis 2020; 35(7): 1243- 53. https://doi.org/10.1007/s00384-020-03577-z
APA Tırnova İ, Isik O, Yılmazlar T (2023). Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. , 197 - 203. 10.47717/turkjsurg.2023.5946
Chicago Tırnova İsmail,Isik Ozgen,Yılmazlar Tuncay Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. (2023): 197 - 203. 10.47717/turkjsurg.2023.5946
MLA Tırnova İsmail,Isik Ozgen,Yılmazlar Tuncay Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. , 2023, ss.197 - 203. 10.47717/turkjsurg.2023.5946
AMA Tırnova İ,Isik O,Yılmazlar T Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. . 2023; 197 - 203. 10.47717/turkjsurg.2023.5946
Vancouver Tırnova İ,Isik O,Yılmazlar T Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. . 2023; 197 - 203. 10.47717/turkjsurg.2023.5946
IEEE Tırnova İ,Isik O,Yılmazlar T "Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer." , ss.197 - 203, 2023. 10.47717/turkjsurg.2023.5946
ISNAD Tırnova, İsmail vd. "Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer". (2023), 197-203. https://doi.org/10.47717/turkjsurg.2023.5946
APA Tırnova İ, Isik O, Yılmazlar T (2023). Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. Turkish Journal of Surgery, 39(3), 197 - 203. 10.47717/turkjsurg.2023.5946
Chicago Tırnova İsmail,Isik Ozgen,Yılmazlar Tuncay Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. Turkish Journal of Surgery 39, no.3 (2023): 197 - 203. 10.47717/turkjsurg.2023.5946
MLA Tırnova İsmail,Isik Ozgen,Yılmazlar Tuncay Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. Turkish Journal of Surgery, vol.39, no.3, 2023, ss.197 - 203. 10.47717/turkjsurg.2023.5946
AMA Tırnova İ,Isik O,Yılmazlar T Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. Turkish Journal of Surgery. 2023; 39(3): 197 - 203. 10.47717/turkjsurg.2023.5946
Vancouver Tırnova İ,Isik O,Yılmazlar T Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer. Turkish Journal of Surgery. 2023; 39(3): 197 - 203. 10.47717/turkjsurg.2023.5946
IEEE Tırnova İ,Isik O,Yılmazlar T "Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer." Turkish Journal of Surgery, 39, ss.197 - 203, 2023. 10.47717/turkjsurg.2023.5946
ISNAD Tırnova, İsmail vd. "Risk factors affecting oncological outcomes of surgical resections for middle and lower rectal cancer". Turkish Journal of Surgery 39/3 (2023), 197-203. https://doi.org/10.47717/turkjsurg.2023.5946